New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Macrophages produce heat from brown adipose tissue in response to cold, study reveals

Macrophages produce heat from brown adipose tissue in response to cold, study reveals

by University of TsukubaGraphical abstract. Credit:Cell Reports(2024). DOI: 10.1016/j.celrep.2024.113978Researchers from University of Tsukuba have elucidated the molecular mechanism
Immunology & Rheumatology March 27,2024
Macrophages produce heat from brown adipose tissue in response to cold, study reveals

Macrophages produce heat from brown adipose tissue in response to cold, study reveals

by University of TsukubaGraphical abstract. Credit:Cell Reports(2024). DOI: 10.1016/j.celrep.2024.113978Researchers from University of Tsukuba have elucidated the molecular mechanism
Immunology & Rheumatology March 27,2024
Lymph node-like biomaterial scaffold for augmenting CAR-T cell therapy

Lymph node-like biomaterial scaffold for augmenting CAR-T cell therapy

byScience China PressOn the top, the schematic illustration shows the structure of scaffold, the seeding and proliferation of CAR-T cells within the scaffold after intratumor injection. On the b
Immunology & Rheumatology March 27,2024
Lymph node-like biomaterial scaffold for augmenting CAR-T cell therapy

Lymph node-like biomaterial scaffold for augmenting CAR-T cell therapy

byScience China PressOn the top, the schematic illustration shows the structure of scaffold, the seeding and proliferation of CAR-T cells within the scaffold after intratumor injection. On the b
Immunology & Rheumatology March 27,2024
Research unveils metabolic strategies to enhance CAR-T cell therapy

Research unveils metabolic strategies to enhance CAR-T cell therapy

by Cactus CommunicationsChimeric antigen receptor T (CAR-T) cell therapy effectively treats hematological tumors but struggles due to metabolic challenges in the tumor microenvironment. Tumor cells di
Immunology & Rheumatology March 27,2024
Research unveils metabolic strategies to enhance CAR-T cell therapy

Research unveils metabolic strategies to enhance CAR-T cell therapy

by Cactus CommunicationsChimeric antigen receptor T (CAR-T) cell therapy effectively treats hematological tumors but struggles due to metabolic challenges in the tumor microenvironment. Tumor cells di
Immunology & Rheumatology March 27,2024
New study reveals insights into COVID-19 antibody response durability

New study reveals insights into COVID-19 antibody response durability

byUniversity of Maryland School of MedicineCredit: CC0 Public DomainResearchers at the Institute of Human Virology (IHV) at the University of Maryland School of Medicine havepublished&nbsp
Public Health & Prevention March 27,2024
New study reveals insights into COVID-19 antibody response durability

New study reveals insights into COVID-19 antibody response durability

byUniversity of Maryland School of MedicineCredit: CC0 Public DomainResearchers at the Institute of Human Virology (IHV) at the University of Maryland School of Medicine havepublished&nbsp
Public Health & Prevention March 27,2024
Research discovers gene that links deafness to inner ear cell death

Research discovers gene that links deafness to inner ear cell death

JANUARY 8, 2024by Levi Gadye,University of California, San FranciscoGraphical abstract. Credit:JCI Insight(2023). DOI: 10.1172/jci.insight.172665Researchers have found a gene that li
ENT & HN March 27,2024
Research discovers gene that links deafness to inner ear cell death

Research discovers gene that links deafness to inner ear cell death

JANUARY 8, 2024by Levi Gadye,University of California, San FranciscoGraphical abstract. Credit:JCI Insight(2023). DOI: 10.1172/jci.insight.172665Researchers have found a gene that li
ENT & HN March 27,2024
What you need to know about new treatments for children with peanut allergies

What you need to know about new treatments for children with peanut allergies

by Dr Li Huang, et al.,University of MelbourneCredit: Unsplash/CC0 Public DomainFor many people peanuts are a healthy snacking option, but for those people with an allergy, peanuts can be a seri
Immunology & Rheumatology March 27,2024
What you need to know about new treatments for children with peanut allergies

What you need to know about new treatments for children with peanut allergies

by Dr Li Huang, et al.,University of MelbourneCredit: Unsplash/CC0 Public DomainFor many people peanuts are a healthy snacking option, but for those people with an allergy, peanuts can be a seri
Immunology & Rheumatology March 27,2024
How the body's immune response to bacterial infections could cause detrimental inflammation

How the body's immune response to bacterial infections could cause detrimental inflammation

byNanyang Technological UniversityA. Representative images of A549-ASC-GFP-NLRP1 (upper panel) or ZAKɑ KO A549-ASCGFP-NLRP1 (lower panel) reporter cells Images of GFP and DAPI fluorescence were
Immunology & Rheumatology March 27,2024
How the body's immune response to bacterial infections could cause detrimental inflammation

How the body's immune response to bacterial infections could cause detrimental inflammation

byNanyang Technological UniversityA. Representative images of A549-ASC-GFP-NLRP1 (upper panel) or ZAKɑ KO A549-ASCGFP-NLRP1 (lower panel) reporter cells Images of GFP and DAPI fluorescence were
Immunology & Rheumatology March 27,2024
Researchers find new way to curb asthma attacks

Researchers find new way to curb asthma attacks

by Dennis ThompsonA protein that shuts down immune cells in the lungs could be key to a new treatment for asthma attacks, a new report says.The naturally occurringprotein, called Piezo1, prevent
Immunology & Rheumatology March 27,2024
Researchers find new way to curb asthma attacks

Researchers find new way to curb asthma attacks

by Dennis ThompsonA protein that shuts down immune cells in the lungs could be key to a new treatment for asthma attacks, a new report says.The naturally occurringprotein, called Piezo1, prevent
Immunology & Rheumatology March 27,2024
Examining inflammatory bowel disease after a stem cell transplant

Examining inflammatory bowel disease after a stem cell transplant

byUniversity of BaselColon sections of the index patient in active IBDvs. clinical remission (under infliximab therapy) were stained by immune histology for CD5 (a pan T cell marker) and f
Immunology & Rheumatology March 27,2024
Examining inflammatory bowel disease after a stem cell transplant

Examining inflammatory bowel disease after a stem cell transplant

byUniversity of BaselColon sections of the index patient in active IBDvs. clinical remission (under infliximab therapy) were stained by immune histology for CD5 (a pan T cell marker) and f
Immunology & Rheumatology March 27,2024
CARv3-TEAM-E T-cell treatment beneficial for recurrent glioblastoma

CARv3-TEAM-E T-cell treatment beneficial for recurrent glioblastoma

by Elana GotkineFor patients with recurrent glioblastoma, treatment with chimeric antigen receptor (CAR) T-cells engineered to target the epidermal growth factor receptor (EGFR) variant III tumor-spec
Immunology & Rheumatology March 27,2024
CARv3-TEAM-E T-cell treatment beneficial for recurrent glioblastoma

CARv3-TEAM-E T-cell treatment beneficial for recurrent glioblastoma

by Elana GotkineFor patients with recurrent glioblastoma, treatment with chimeric antigen receptor (CAR) T-cells engineered to target the epidermal growth factor receptor (EGFR) variant III tumor-spec
Immunology & Rheumatology March 27,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com